Jyothy Labs Q1 FY27 Unaudited Results: Profit Declines to ₹47.64 Crore
Jyothy Labs reported un-audited results for the quarter ended June 30, 2026. Net profit decreased to ₹47.64 crore from ₹96.79 crore in the year-ago period. Revenue from operations rose to ₹773.40 crore from ₹751.21 crore. Basic EPS fell to ₹1.30 from ₹2.64.
The decline in profitability, despite a slight increase in revenue, is a material event that could impact investor sentiment and the company's stock performance.
The net profit and earnings per share have significantly declined compared to the same quarter last year, indicating a negative financial performance for the period.
Jyothy Labs Limited has announced its un-audited financial results for the quarter ended June 30, 2026. The company's Board of Directors approved these results in a meeting held on August 12, 2026, which commenced at 10:45 a.m. and concluded at 12:50 p.m.
For the quarter ended June 30, 2026, Jyothy Labs reported a total income of ₹791.05 crore (79,105 Lakhs), a slight increase from ₹770.65 crore (77,065 Lakhs) in the corresponding quarter of the previous year. However, total expenses rose significantly to ₹726.07 crore (72,607 Lakhs) from ₹643.12 crore (64,312 Lakhs) in the same period last year, primarily due to a substantial increase in the cost of materials consumed.
Consequently, the net profit for the quarter stood at ₹47.64 crore (4,764 Lakhs), a notable decrease from ₹96.79 crore (9,679 Lakhs) in the quarter ended June 30, 2025. Basic earnings per share (EPS) also declined to ₹1.30 from ₹2.64 in the prior year's comparable quarter.
The company's revenue from operations for the quarter was ₹773.40 crore (77,340 Lakhs), up from ₹751.21 crore (75,121 Lakhs) in Q1 FY26. Segment-wise, Fabric Care revenue increased to ₹398.89 crore (39,889 Lakhs) from ₹349.48 crore (34,948 Lakhs) year-on-year. Home Care revenue remained stable at ₹280.19 crore (28,019 Lakhs) compared to ₹307.80 crore (30,780 Lakhs) in Q1 FY26. Personal Care revenue was ₹94.32 crore (9,432 Lakhs), similar to ₹93.93 crore (9,393 Lakhs) in the previous year.
The financial results were reviewed by the statutory auditors, B S R & Co. LLP. The company has also revised its internal management segment reporting structure, with comparative segment information re-stated.
What to do with a filing like this
Jyothy Labs Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jyothy Labs Limited. Read the original for the full detail.